Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MoonLake Immunotherapeutics (MLTX) Change in Cash (2021 - 2026)

MoonLake Immunotherapeutics' Change in Cash history spans 6 years, with the latest figure at -$36.0 million for Q1 2026.

  • Quarterly Change in Cash fell 139.53% to -$36.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $26.9 million through Mar 2026, up 114.41% year-over-year, with the annual reading at $154.1 million for FY2025, 156.91% up from the prior year.
  • Change in Cash came in at -$36.0 million for Q1 2026, down from -$16.2 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $451.7 million in Q2 2023 to a low of -$195.2 million in Q4 2024.
  • The 5-year median for Change in Cash is $7.3 million (2024), against an average of $17.1 million.
  • Year-over-year, Change in Cash plummeted 3259.8% in 2022 and then surged 7928.12% in 2023.
  • MoonLake Immunotherapeutics' Change in Cash stood at -$1.7 million in 2022, then soared by 7928.12% to $133.0 million in 2023, then crashed by 246.79% to -$195.2 million in 2024, then surged by 91.69% to -$16.2 million in 2025, then tumbled by 122.13% to -$36.0 million in 2026.
  • Per Business Quant, the three most recent readings for MLTX's Change in Cash are -$36.0 million (Q1 2026), -$16.2 million (Q4 2025), and $44.1 million (Q3 2025).